마이크로 RNA 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The MicroRNA Market size is expected to reach USD 29.23 Billion in 2034 from USD 2.80 Billion (2025) growing at a CAGR of 29.76% during 2026-2034.

The global microRNA market is gaining momentum due to growing research in molecular biology and genetic diagnostics. MicroRNAs play a crucial role in gene regulation and disease progression, making them valuable biomarkers for cancer and other chronic conditions. Rising investments in genomics research are significantly supporting market expansion.

Key growth drivers include advancements in RNA sequencing technologies and increasing adoption of personalized medicine approaches. Pharmaceutical companies are exploring microRNA-based therapeutics, strengthening the research pipeline. Government funding and academic collaborations further contribute to market growth.

Looking ahead, technological improvements in RNA delivery systems and diagnostic platforms are expected to enhance clinical applications. The integration of microRNA research into precision medicine strategies may open new treatment opportunities, supporting long-term market development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Services

• Specimen
• Service Type

By Products

• Instruments
• Consumables

By Application

• Cancer
• Infectious Diseases
• Immunological Disorder
• Cardiovascular Disease
• Neurological Disease
• Others

By End-Use

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Others

COMPANIES PROFILED

• Merck KGaA, Thermo Fisher Scientific Inc, Horizon Discovery Ltd, Synlogic, Qiagen, GeneCopoeia Inc, New England Biolabs, Quantabio, NanoString, BioGenex, SeqMatic LLC, Miltenyi Biotec, Sistemic Scotland Limited, Biodynamics Laboratory Inc, OriGene Tec
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MICRORNA MARKET: BY SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Services
• 4.2. Specimen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Service Type Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MICRORNA MARKET: BY PRODUCTS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Products
• 5.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MICRORNA MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Immunological Disorder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiovascular Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Neurological Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MICRORNA MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Biotechnology & Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic & Government Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MICRORNA MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Services
  • 8.2.2 By Products
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Services
  • 8.3.2 By Products
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Services
  • 8.4.2 By Products
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Services
  • 8.5.2 By Products
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Services
  • 8.6.2 By Products
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MICRORNA INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Merck KGaA
  • 10.2.2 Thermo Fisher Scientific Inc
  • 10.2.3 Horizon Discovery Ltd
  • 10.2.4 Synlogic
  • 10.2.5 Qiagen
  • 10.2.6 GeneCopoeia Inc
  • 10.2.7 New England Biolabs
  • 10.2.8 Quantabio
  • 10.2.9 NanoString
  • 10.2.10 BioGenex
  • 10.2.11 SeqMatic LLC
  • 10.2.12 Miltenyi Biotec
  • 10.2.13 Sistemic Scotland Limited
  • 10.2.14 Biodynamics Laboratory Inc
  • 10.2.15 OriGene Tec